Hematological Malignancies

Showing 51 - 75 of 96

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumors, Malignant Melanoma, Hematological Malignancies Trial in Chicago (Immunoablative Hematopoietic PBSC Transplant, Busulfan

Completed
  • Tumors
  • +4 more
  • Immunoablative Hematopoietic PBSC Transplant
  • +2 more
  • Chicago, Illinois
    Lurie Children's Hospital
Aug 28, 2019

Antibacterial Prophylaxis, Hematological Malignancies, Allogenetic Hematopoietic Stem Cell Transplantation Trial in Guangzhou

Unknown status
  • Antibacterial Prophylaxis
  • +3 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Nov 6, 2018

Hematological Malignancies Trial in Houston (ABT-751)

Completed
  • Hematological Malignancies
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Oct 30, 2018

Hematological Malignancies Trial in Houston (Ibandronate, Vitamin Supplements)

Completed
  • Hematological Malignancies
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 12, 2018

Hematological Malignancies Trial in Charleston (Regimen A, Regimen B, Regimen C)

Terminated
  • Hematological Malignancies
  • Regimen A
  • +2 more
  • Charleston, South Carolina
    Medical University of South Carolina
Jun 13, 2018

Hematological Malignancies Trial in Detroit (Tacrolimus and Thymoglobulin)

Completed
  • Hematological Malignancies
  • Tacrolimus and Thymoglobulin
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 16, 2018

Invasive Fungal Disease, Chronic Disseminated Candidiasis, Hematological Malignancies Trial in Paris (18F-FDG PET Scan)

Completed
  • Invasive Fungal Disease
  • +4 more
  • 18F-FDG PET Scan
  • Paris, France
    Service des Maladies Infectieuses et Tropicales - Centre d'Infec
Apr 27, 2018

Hematological Malignancies Trial in Nice (LP in a seated position then LP in a lying position, LP in a lying position then LP in

Completed
  • Hematological Malignancies
  • LP in a seated position then LP in a lying position
  • LP in a lying position then LP in a seated position
  • Nice, France
    CHU de Nice
Mar 8, 2018

Hematological Malignancies Trial in Durham (Naive T Cell Depleted Donor Lymphocyte Infusion)

Completed
  • Hematological Malignancies
  • Naive T Cell Depleted Donor Lymphocyte Infusion
  • Durham, North Carolina
    Duke University Medical Center
Feb 12, 2018

Hematological Malignancies Trial in Memphis (drug, biological, radiation, device)

Terminated
  • Hematological Malignancies
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 10, 2018

Hematological Malignancies Trial in Philadelphia (Haploidentical Allogeneic Transplantation)

Completed
  • Hematological Malignancies
  • Haploidentical Allogeneic Transplantation
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Jan 3, 2018

Hematological Malignancies Trial in Beijing (IM19 CAR-T, Fludarabine, Cyclophosphamide)

Unknown status
  • Hematological Malignancies
  • IM19 CAR-T
  • +2 more
  • Beijing, Beijing, China
    Peking University Third Hospital
Nov 16, 2017

Combination of Post-transplant High Dose Cyclophosphamide,

Unknown status
  • Hematological Malignancies
    • Candiolo, Italy
    • +1 more
    Sep 1, 2017

    Hematological Malignancies Trial in Ann Arbor (procedure, drug, radiation)

    Completed
    • Hematological Malignancies
    • Full intensity, double umbilical cord, stem cell transplant
    • +4 more
    • Ann Arbor, Michigan
      University of Michigan Cancer Center
    Nov 3, 2016

    Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)

    Completed
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • Hematological Malignancies
      • (no location specified)
      Aug 4, 2016

      Intensive Care in Critically Ill Cancer Haematological Patients:

      Completed
      • Hematological Malignancies
        • Paris, France
          Hôpital Saint-Louis, AP-HP
        Apr 15, 2016

        Hematological Malignancies Trial in Melbourne (aereobic plus resisted exercise, aerobic plus active exercise, No formal exercise

        Unknown status
        • Hematological Malignancies
        • aereobic plus resisted exercise
        • +2 more
        • Melbourne, Victoria, Australia
          Alfred hospital Physiotherapy dept,
        Jan 6, 2016

        Umbilical Cord Blood, Stem Cell Transplantation, Hematological Malignancies Trial (ex vivo expansion)

        Withdrawn
        • Umbilical Cord Blood
        • +2 more
        • ex vivo expansion
        • (no location specified)
        Dec 1, 2015

        GVHD, Hematological Malignancies Trial in Jerusalem (ApoCell)

        Unknown status
        • Graft Versus Host Disease
        • Hematological Malignancies
        • ApoCell
        • Jerusalem, Israel
          Department of Bone Marrow Transplantation
        Jun 10, 2015

        Hematological Malignancies Trial in Pavia

        Unknown status
        • Hematological Malignancies
          • Pavia, Italy
            Department of Hematology Oncology, IRCCS Policlinico San Matteo
          Jun 4, 2015

          The Good Patient Study

          Completed
          • Solid Tumor
          • +2 more
          • Interview
          • Washington, District of Columbia
          • +1 more
          Jun 3, 2015

          Solid Tumors, Hematological Malignancies Trial in East Greenwich, Providence (Molecular Analysis of Cancer)

          Unknown status
          • Solid Tumors
          • Hematological Malignancies
          • Molecular Analysis of Cancer
          • East Greenwich, Rhode Island
          • +2 more
          Aug 26, 2014

          Hematological Malignancies Trial in Worldwide (HSV-TK)

          Completed
          • Hematological Malignancies
          • HSV-TK
          • Hannover, Germany
          • +7 more
          May 29, 2014

          Rate of Itraconazole Injection in Treating Immunocompromised

          Completed
          • Hematological Malignancies
          • +2 more
          • Pts. w/ neutropenic fever associated w/ hematologic malignancy
          • (no location specified)
          May 14, 2014

          Hematological Malignancies Trial in Washington, Houston, Toronto (Obatoclax mesylate (GX15-070MS))

          Completed
          • Hematological Malignancies
          • Obatoclax mesylate (GX15-070MS)
          • Washington, District of Columbia
          • +2 more
          May 9, 2014